newsfilter
← Latest News
Business Wire·

AVEO Oncology Announces Appointment of Jeb Ledell as Chief Operating Officer

- Former chief operating officer of Enzyvant Therapeutics brings over 20 years of biotech leadership experience - AVEO Oncology (NASDAQ:AVEO), a commercial stage, oncology-focused biopharmaceutical company, today announced the appointment of Jeb Lede